BIM
SNOA icon

Bogle Investment Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Bogle Investment Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-21
Closed -$50K – 351
2013
Q3 		$50K Sell
21
-46
-69% -$112K 0.01% 304
2013
Q2 		$154K Buy
+67
New +$239K 0.02% 274

Other funds holding SNOA

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bogle Investment Management's SNOA Position: Q4 2013 in Review

Bogle Investment Management sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2013, closing a stake of 21 shares — an estimated $50K sold.

Bogle Investment Management first reported a position in SNOA in Q2 2013 and held it in 2 quarters. The position peaked at $154K in Q2 2013. 19 funds tracked by Wall St. Rank hold SNOA as of Q4 2013.

  • Bogle Investment Management reported no remaining Sonoma Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Bogle Investment Management sold 21 Sonoma Pharmaceuticals shares in Q4 2013, an estimated $50K.
  • Bogle Investment Management first reported a position in Sonoma Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • Bogle Investment Management's Sonoma Pharmaceuticals position peaked at $154K in Q2 2013.
  • 19 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2013.

Based on Bogle Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.